Pilgrim's Pride Corporation PPC
Set alert
27.22 USD -1.43 -4.98%
As of Nov 3, 11:17 AM ET
27.04 Day range 28.17
25.00 52-week range 44.84
- YTD
- -30.20%
- 1 year
- -28.25%
- Open
- 28.12
- Prev close
- 28.64
- Mkt cap
- 6.48B
- Vol
- 250.32K
- Avg vol
- 1.39M
- EPS
- 1.34
- P/E
- 20.31
- Div yield
- 0.00%
More statistics
- Low
- 27.04
- High
- 28.17
- Forward P/E
- 11.20
- Beta
- 0.34
- Short ratio
- 4.29
- Inst. own
- 20.60%
- Dividend
- 0.00
- Ex-div date
- Aug 19, 2025
- Earnings
- Feb 10, 2027
- 50-d avg
- 29.10
- 200-d avg
- 32.45
- 1y target
- 32.57
1Y chart
Events in this range
- Feb 11, 2026Earnings: 0.68; estimate 0.78; surprise -12.82%
- Apr 9, 2026Rating: Goldman Sachs · Neutral → Neutral
- Apr 29, 2026Earnings: 0.51; estimate 0.69; surprise -26.09%
- May 1, 2026Rating: Barclays · Equal-Weight → Overweight
- May 19, 2026Rating: UBS · — → Neutral
- Jul 2, 2026Rating: B of A Securities · Neutral → Neutral
- Jul 29, 2026Earnings: 0.64; estimate 0.703; surprise -8.96%
- Aug 7, 2026Rating: UBS · Neutral → Neutral
- Oct 28, 2026Earnings: 0.49; estimate 0.556; surprise -11.87%
- Oct 30, 2026Rating: Barclays · Overweight → Overweight
Signals (50)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2026 | 1 day ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| RSI: Oversold | Apr 29, 2026 | 6 months ago |
Newest 20 of 50.
Analyst view
Consensus: hold
Hold
Price target (mean) 32.57 +19.7% upside
Now 27.22
- Target (low)
- 28.00
- Target (mean)
- 32.57
- Target (high)
- 40.00
Ratings (0m) 8 2 buy · 6 hold · 0 sell
- Strong buy1
- Buy1
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.4475 | 0.42 – 0.49 | 0.68 | -34.2% | 4.57B | +1.2% | 4 |
| Next quarter | 0.43333 | 0.32 – 0.53 | 0.51 | -15.0% | 4.54B | +0.1% | 3 |
| Current year | 2.06 | 1.96 – 2.13 | 5.17 | -60.1% | 18.39B | -0.6% | 5 |
| Next year | 2.56 | 1.87 – 3.14 | 2.06 | +23.9% | 18.90B | +2.8% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 7, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 2, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| May 19, 2026 | UBS | Initiated | — | Neutral |
| May 1, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Apr 9, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 25, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 13, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Dec 9, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jun 23, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Mar 17, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Nov 1, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 1, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Sep 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 28, 2024 | Argus Research | Maintained | Buy | Buy |
| Aug 15, 2024 | B of A Securities | Downgrade | Buy | Neutral |
| Aug 12, 2024 | BMO Capital | Downgrade | Outperform | Market Perform |
| Aug 2, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Aug 2, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 25, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 23, 2024 | Argus Research | Maintained | Buy | Buy |
| Jul 10, 2024 | B of A Securities | Maintained | Buy | Buy |
| Jun 18, 2024 | Argus Research | Initiated | — | Buy |
| Apr 17, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Apr 16, 2024 | Barclays | Downgrade | Overweight | Equal-Weight |
| Apr 15, 2024 | B of A Securities | Maintained | Buy | Buy |
| Feb 27, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 27, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 27, 2024 | Barclays | Maintained | Overweight | Overweight |